Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What market expansion outlook does the Third-Generation Sequencing Technology Market show for the 2026–2030 period?
The market size for third-generation sequencing technology has experienced rapid expansion recently. This market is projected to expand from $14 billion in 2025 to $15.96 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 14.0%. Historically, this growth can be linked to factors such as genomics research funding, the limitations inherent in short-read sequencing, increased adoption in academic research, a surge in rare disease studies, and continuous technology innovation.
The third-generation sequencing technology market size is projected to experience substantial growth in the coming years. It is anticipated to reach $26.71 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.7%. This expansion during the forecast period can be attributed to the proliferation of precision medicine, increased adoption of clinical diagnostics, a reduction in sequencing costs, integration with AI analytics, and various population genomics initiatives. Key trends expected in the forecast period include long-read sequencing technologies, real-time DNA sequencing, broader clinical genomics adoption, single-molecule sequencing, and the development of portable sequencing platforms.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28340&type=smp
What Drivers Are Shaping The Development Of The Third-Generation Sequencing Technology Market?
The expanding integration of personalized medicine is anticipated to fuel the expansion of the third-generation sequencing technology market moving ahead. Personalized medicine is defined as a healthcare method that customizes treatment and prevention plans based on an individual’s distinct genetic profile, way of life, and surroundings. The growing embrace of personalized medicine largely stems from progress in genomics, allowing for the accurate detection of genetic differences and customized therapies for patients. Third-generation sequencing technology improves personalized medicine by providing long-read, highly accurate genomic information, which facilitates the precise identification of genetic variations. This technology aids in developing customized treatment strategies through its comprehensive insights into individual genomes, thereby enhancing clinical results and progressing precision healthcare. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, marking a considerable rise from the 12 approved in 2022. Consequently, the rising prevalence of personalized medicine is stimulating the growth of the third-generation sequencing technology market.
Which Segments Are Contributing To The Growth Of The Third-Generation Sequencing Technology Market?
The third-generation sequencing technology market covered in this report is segmented –
1) By Technology Type: Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing
2) By Workflow: Sample Preparation, Sequencing, Data Analysis, Data Interpretation, Data Storage And Management
3) By Application: Genomics, Transcriptomics, Epigenomics, Metagenomics, Personalized Medicine, Synthetic Biology
4) By End-User: Academic Institutions, Clinical Laboratories, Pharmaceutical And Biotechnology Companies, Research Organizations, Government And Non-Profit Organizations
Subsegments:
1) By Single-Molecule Real-Time Sequencing (SMRT): Zero-Mode Waveguides (ZMWs), Circular Consensus Sequencing (CCS), High-Fidelity (HiFi) Reads
2) By Nanopore Sequencing: Portable Nanopore Sequencers, Benchtop Nanopore Sequencers, High-Throughput Nanopore Platforms
Which Market Trends Are Opening Growth Opportunities In The Third-Generation Sequencing Technology Market?
Major companies operating in the third-generation sequencing technology market are concentrating on developing advanced sequencing platforms, such as ultra-rapid and scalable sequencing systems, to enhance research efficiency, improve clinical applicability, and decrease turnaround times and costs. These ultra-rapid and scalable sequencing systems refer to innovative technologies that facilitate high-throughput, real-time genomic analysis with exceptional speed and accuracy, enabling comprehensive genomic profiling across diverse applications. For instance, in February 2025, Roche Holding AG, a Switzerland-based pharmaceutical company, launched its Sequencing by Expansion (SBX) technology. This is a fully integrated, next-generation sequencing system featuring a patented biochemical process that encodes DNA or RNA sequences into measurable surrogate polymers called Xpandomers, allowing for highly accurate single-molecule nanopore sequencing. The SBX platform includes ultra-rapid, scalable sequencing capabilities and automated data analysis, delivering whole-genome sequencing results in hours rather than days without extensive manual intervention.
Who Are The Prominent Global Companies Shaping The Third-Generation Sequencing Technology Market Landscape?
Major companies operating in the third-generation sequencing technology market are Oxford Nanopore Technologies, Pacific Biosciences, Quantapore, Ultima Genomics, BGI Genomics, MGI Tech, Complete Genomics, Stratos Genomics, VisiGen Biotechnologies, Helicos Biosciences, Genia Technologies, Electronic Bio Sciences, Quantum Biosystems, Base4 Innovation, Nabsys, Chronix Biomedical, Roche, Nanopore Diagnostics, GenapSys, SomaLogic
Access The Complete Report For Deeper Market Insights:
Which Region Is Projected To Lead The Third-Generation Sequencing Technology Market During The Forecast Period?
North America was the largest region in the third-generation sequencing technology market in 2025. The regions covered in the third-generation sequencing technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Third-Generation Sequencing Technology Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28340&type=smp
Browse Through More Reports Similar to the Global Third-Generation Sequencing Technology Market 2026, By The Business Research Company
Clinical Oncology Next Generation Sequencing Global Market Report 2026
Dna Sequencing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Clinical Next Generation Sequencing Ngs Data Analysis Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company